rs376133710
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_147127.5(EVC2):c.3121C>T(p.Gln1041Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_147127.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVC2 | NM_147127.5 | c.3121C>T | p.Gln1041Ter | stop_gained | 18/22 | ENST00000344408.10 | NP_667338.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVC2 | ENST00000344408.10 | c.3121C>T | p.Gln1041Ter | stop_gained | 18/22 | 1 | NM_147127.5 | ENSP00000342144 | P2 | |
EVC2 | ENST00000310917.6 | c.2881C>T | p.Gln961Ter | stop_gained | 18/22 | 1 | ENSP00000311683 | A2 | ||
EVC2 | ENST00000475313.5 | c.2881C>T | p.Gln961Ter | stop_gained, NMD_transcript_variant | 18/23 | 1 | ENSP00000431981 | |||
EVC2 | ENST00000509670.1 | c.*1514C>T | 3_prime_UTR_variant, NMD_transcript_variant | 19/23 | 1 | ENSP00000423876 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249074Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134816
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461304Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 726938
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74344
ClinVar
Submissions by phenotype
Ellis-van Creveld syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Aug 01, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 11, 2024 | Variant summary: EVC2 c.3121C>T (p.Gln1041X) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 4e-06 in 249074 control chromosomes (gnomAD). c.3121C>T has been reported in the literature in an individual affected with short-rib polydactyly syndrome (Zhang_2018). The following publication has been ascertained in the context of this evaluation (PMID: 29068549). ClinVar contains an entry for this variant (Variation ID: 446685). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Type IV short rib polydactyly syndrome Pathogenic:2
Likely pathogenic, no assertion criteria provided | research | Dan Cohn Lab, University Of California Los Angeles | Jun 01, 2017 | - - |
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 10, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 446685). This premature translational stop signal has been observed in individual(s) with short-rib polydactyly syndrome (PMID: 29068549). This variant is present in population databases (rs376133710, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Gln1041*) in the EVC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC2 are known to be pathogenic (PMID: 17024374, 19810119, 19876929). - |
EVC2-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 24, 2023 | The EVC2 c.3121C>T variant is predicted to result in premature protein termination (p.Gln1041*). This variant has been reported in an individual with short rib-polydactyly syndrome, type 4 (SRPS IV, Table S3, Zhang et al. 2018. PubMed ID: 29068549). This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD. Nonsense variants in EVC2 are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at